8 unchanged sentences
Performance Graph
−Removed: The stock performance graph below illustrates a comparison of the total cumulative stockholder return on our common stock since December 31, 2017 to the Nasdaq Composite and a composite of eleven Nasdaq Pharmaceutical and Specialty Pharmaceutical Stocks which most closely compare to our Company - Avadel Pharmaceuticals plc, Harrow Health, Inc., Eagle Pharmaceuticals, Inc., Assertio Holdings, Inc., HLS Therapeutics, EyePoint Pharmaceuticals, Inc., Eton Pharmaceuticals, Inc., Theratechnologies Inc., Impel Pharmaceuticals Inc., Acorda Therapeutics Inc.
−Removed: and AcelRX Pharmaceuticals, Inc.
+Added: The stock performance graph below illustrates a comparison of the total cumulative stockholder return on our common stock since December 31, 2018 to the Nasdaq Composite and a composite of ten Nasdaq Pharmaceutical and Specialty Pharmaceutical Stocks which most closely compare to our Company - Avadel Pharmaceuticals plc, Harrow Health, Inc., Eagle Pharmaceuticals, Inc., Assertio Holdings, Inc., HLS Therapeutics Inc., EyePoint Pharmaceuticals, Inc., Eton Pharmaceuticals, Inc., Theratechnologies Inc., Acorda Therapeutics Inc.
+Added: and Talphera, Inc.
The graph assumes an initial investment of $100 on December 31, 2018, and that all dividends were reinvested.
2 unchanged sentences
In January 2019, the Company’s Board of Directors established the current $10.0 million repurchase program to replace the prior authorizations.
−Removed: We repurchased 367,793 shares and 438,359 shares of common stock for approximately $1.0 million and $1.4 million, and during the years ended December 31, 2022 and 2021, respectively.
+Added: We repurchased 402,143 shares and 367,793 shares of common stock for approximately $0.7 and $1.0 million during the years ended December 31, 2023 and 2022, respectively.
The following table summarizes the activity, by month, during the fourth quarter of 2023:
15 unchanged sentences
(1) Of this amount, 25,000 shares were repurchased directly in private purchases at the then-current fair market value of common stock.
+Added: (2) Of this amount, 971 shares were repurchased directly in private purchases at the then-current fair market value of common stock.
Compared sentence by sentence after normalising whitespace, quotation marks, case and digits, so re-formatting and restated figures do not read as changed language. Wording changes appear as one removal and one addition. The current filing and the prior one are authoritative.